S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ELTX Elicio Therapeutics Inc

7.97

-0.30 (-3.63%)

Mar 06 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Elicio Therapeutics (NASDAQ:ELTX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Elicio Therapeutics Charts.

Elicio Therapeutics (NASDAQ:ELTX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Elicio Therapeutics Charts.

Elicio Therapeutics Inc News

Form 8-K - Current report
Wednesday 5 March 2025 (1 day ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 30 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 30 January 2025 (1 month ago) • Edgar (US Regulatory)

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Thursday 30 January 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 23 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 22 January 2025 (1 month ago) • Edgar (US Regulatory)

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy
Wednesday 22 January 2025 (1 month ago) • GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 7 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 12 December 2024 (3 months ago) • Edgar (US Regulatory)

More Elicio Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions